CN108478527B - Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle - Google Patents

Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle Download PDF

Info

Publication number
CN108478527B
CN108478527B CN201810353345.3A CN201810353345A CN108478527B CN 108478527 B CN108478527 B CN 108478527B CN 201810353345 A CN201810353345 A CN 201810353345A CN 108478527 B CN108478527 B CN 108478527B
Authority
CN
China
Prior art keywords
sericin
gamma
polyglutamic acid
self
assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810353345.3A
Other languages
Chinese (zh)
Other versions
CN108478527A (en
Inventor
苏小舟
栗蕾
陈劲松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongyuan University of Technology
Original Assignee
Zhongyuan University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongyuan University of Technology filed Critical Zhongyuan University of Technology
Priority to CN201810353345.3A priority Critical patent/CN108478527B/en
Publication of CN108478527A publication Critical patent/CN108478527A/en
Application granted granted Critical
Publication of CN108478527B publication Critical patent/CN108478527B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention discloses a preparation method of self-assembly nano-micelle of sericin and gamma-polyglutamic acid, which solves the technical problem that the self-assembly research between sericin and other proteins or polymers is not available at present, and comprises the following steps: 1): selecting sericin with the molecular weight of 12000-24000Da and gamma-polyglutamic acid with the molecular weight of 10-120 ku; 2) preparing a sericin solution and a gamma-polyglutamic acid solution with the same mass concentration: dissolving sericin and gamma-polyglutamic acid in deionized water respectively to prepare solutions with the same mass concentration and the range of 0.3-2%; 3) and preparing a sericin and gamma-polyglutamic acid self-assembly. The invention utilizes gamma-polyglutamic acid and sericin to prepare the gamma-polyglutamic acid and sericin nano self-assembly by an electrostatic assembly method for the first time, and can be applied to the embedding of anticancer drugs and hydrophobic drugs.

Description

Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle
Technical Field
The invention relates to the field of research and preparation of drug carriers, in particular to a preparation method and application of a sericin and gamma-polyglutamic acid self-assembly nano drug sustained-release micelle, which is prepared from sericin and gamma-polyglutamic acid with higher molecular weights as raw materials.
Background
Sericin is a natural macromolecular protein wrapped on the surface layer of silk fibroin and is a main protein constituting silk, sericin is used as a byproduct in the textile industry and is discarded, about 50000 tons of sericin is treated as waste every year, and a large amount of natural protein resources are wasted. Sericin has good biological activity, anti-tumor activity and cell adhesion, which lays a foundation for the application of sericin in the fields of biological medicines and health care products, and a novel mucosa adhesion high polymer is prepared by polymerization reaction of sericin and Acrylic Acid (AA), but the polymerization method is a toxic operation process. At present, only reports about the assembly research of sericin in a solution, and no research reports about the self-assembly between sericin and other proteins or polymers exist.
The polyglutamic acid (gamma-PGA) is an ideal drug carrier, has excellent biocompatibility, degradability, fibroblasticity and film forming property, and is also an excellent targeting drug carrier. Is a natural polymer material harmless to human body and environment. At present, the preparation of drug carriers by assembling gamma-polyglutamic acid with high molecular substances such as ethylene glycol, N-trimethyl chitosan and cholesterol has been reported, but the preparation of controllable nano-micelles by assembling gamma-polyglutamic acid with proteins has not been reported.
Disclosure of Invention
The invention aims to solve the technical problem of toxic operation process of polymerization reaction of sericin and Acrylic Acid (AA), and provides a preparation method and application of a non-toxic and pollution-free sericin and gamma-polyglutamic acid self-assembly nano micelle without any study on self-assembly between sericin and other proteins or polymers.
In order to solve the technical problems, the invention adopts the following technical scheme: a preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle comprises the following steps: 1): selecting sericin with the molecular weight of 12000-24000Da and gamma-polyglutamic acid with the molecular weight of 10-120 ku; 2) preparing a sericin solution and a gamma-polyglutamic acid solution with the same mass concentration: respectively dissolving sericin with the molecular weight of 12000-24000Da and gamma-polyglutamic acid with the molecular weight of 10-120ku in deionized water to prepare solutions with the same mass concentration and the range of 0.3-2%; 3) and preparing a sericin and gamma-polyglutamic acid self-assembly.
1) Selection and preparation of sericin and gamma-polyglutamic acid
To prepare nano-micelle by self-assembly, the sericin should be selected to ensure both sufficient bioactivity and relative water solubility of the protein molecule, otherwise, the water-soluble nano self-assembly cannot be prepared, and thus the application of the nano-micelle is limited. The molecular weight of the sericin is different from tens of thousands to more than 30 tens of thousands due to different extraction methods, the molecular weight of the easily soluble sericin is between 12000-24000Da, the molecular weight of the common sericin is between 50000-98000Da, and the solubility of the easily soluble sericin powder is much higher than that of the common sericin at low temperature and high temperature, so that very favorable conditions are created for the utilization of the sericin, and the sericin can be used for preparing various types of medical biomaterials. The nano-micelle prepared and used by the invention is used in a liquid environment, so the sericin with the molecular weight of 12000-24000Da is selected as one of the raw materials for preparing the self-assembly nano-micelle, and the sericin and the gamma-polyglutamic acid with the molecular weight range can be directly purchased.
The molecular weight of the gamma-polyglutamic acid is generally between 10 and 2000ku, and in order to assemble and prepare the nano-micelle to obtain a thermodynamically stable self-assembly system, the gamma-polyglutamic acid with smaller molecular weight is used in the invention, and the molecular weight of the gamma-polyglutamic acid is selected to be 10 to 120 ku.
2) Preparing sericin solution and gamma-polyglutamic acid solution with the same mass concentration
Preparing a sericin solution and a gamma-polyglutamic acid solution with the same mass concentration: respectively dissolving sericin with the molecular weight of 12000-24000Da and gamma-polyglutamic acid with the molecular weight of 10-120ku in deionized water to prepare solutions with the same mass concentration and the range of 0.3-2%; the preparation and application environment of the self-assembled micelle should be carried out in an acidic environment (pH is less than or equal to 7).
3) Preparation of self-assemblies of sericin and gamma-polyglutamic acid
The preparation principle is as follows: the isoelectric point of gamma-polyglutamic acid is 2.2, and the isoelectric point of sericin is 3.7When two protein solutions are mixed, if the pH value of the system is adjusted to be between the isoelectric points of the two proteins (pH 2.3-3.6), the gamma-polyglutamic acid can carry negative charges and the sericin can carry positive charges, and through experiments, the two substances can not generate precipitation due to complex interaction and protein conformation change, and are assembled and combined through the mutual attraction of the positive charges and the negative charges to form a novel self-assembled nano micelle. The nanomicelles formed at this time are relatively stable, but they are coupled to each other only by electrostatic interaction, and it is necessary to fix their structures in order to keep them in a relatively stable state in various use environments because gamma-polyglutamic acid is linked with-COOH, -NH2and-CO functional groups, whereas silk fibroin contains-COOH, -NH2Active functional groups such as-OH, -HS, etc., therefore, the covalent network structure can be formed by crosslinking in a molecular chain and among molecular chains by using the active chemical groups and a crosslinking agent, so that the assembly structure is stable.
The preparation process comprises the following steps: the preparation steps of the sericin and gamma-polyglutamic acid self-assembly in the step 3) are as follows: a. mixing the sericin solution with the same mass concentration prepared in the step 2) with the gamma-polyglutamic acid solution according to the mass ratio of (4: 1, 2:1, 1:2, 1: 4) to prepare a mixed solution; b. adding 1-3 times volume of phthalic acid-hydrochloric acid buffer solution (pH2.2-3.8) with concentration of 0.05mol/L, fine adjusting pH value to pH2.2-3.7 with 0.01 mol/L hydrochloric acid, placing in an ultrasonic device, and performing ultrasonic treatment for 1-3 hr with ultrasonic power of 300W and frequency of 40 KHZ; c. and c, filling the mixed solution prepared in the step b into a reactor, respectively carrying out constant temperature assembly for 4-12 hours within the temperature range of (20-50 ℃), then adding 0.005-0.1% of cross-linking agent vinyl sulfone, and carrying out cross-linking for 1-3 hours to fix the structure of the micelle, thereby preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid.
4) The application of the sericin and gamma-polyglutamic acid self-assembly nano-micelle is to use the prepared sericin and gamma-polyglutamic acid self-assembly nano-micelle for embedding hydrophobic drugs, select curcumin and β -carotene as embedding drugs to detect the embedding and slow-release performance of the drugs, and the appearance of the self-assembly and the drug embedding data are shown in figure 1-figure 3 and table 1.
The invention utilizes the gamma-polyglutamic acid and the sericin to prepare the gamma-polyglutamic acid and sericin nano self-assembly by the electrostatic assembly method for the first time, can be applied to the embedding of anti-cancer drugs and hydrophobic drugs, and has wider application prospect.
Drawings
FIG. 1 is the self-assembly morphology of example 1;
FIG. 2 is the self-assembly morphology of example 2;
FIG. 3 is the morphology of the self-assembly of example 2.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without inventive effort based on the embodiments of the present invention, are within the scope of the present invention.
Example 1
A preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle comprises the following steps:
1) selection of sericin and gamma-polyglutamic acid
The molecular weight of the silk fibroin is selected to be 12000-24000Da, and the molecular weight of the gamma-polyglutamic acid is selected to be 10 ku.
2) Preparation of sericin and gamma-polyglutamic acid solution
Sericin and gamma-polyglutamic acid with certain mass are respectively dissolved in deionized water to prepare aqueous solution with mass concentration of 0.3% for standby.
3) Preparation of self-assemblies of sericin and gamma-polyglutamic acid
Sericin and gamma-polyglutamic acid solution with mass concentration of 0.3% are mixed according to the mass ratio of 4:1, phthalic acid-hydrochloric acid buffer solution (pH2.2-3.8) with 2 times volume (0.05 mol/L) is added, the pH value is finely adjusted to 3.5 within the range by using 0.01 mol/L hydrochloric acid, and the mixture is placed into an ultrasonic device for ultrasonic treatment for 1 hour with the power of 300W and the frequency of 40 KHZ. And (3) putting the mixed solution into a reactor, assembling for 4 hours at a constant temperature within the temperature range of 20 ℃, adding 0.005% of cross-linking agent vinyl sulfone, and crosslinking for 1 hour to fix the micelle structure, thereby preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid.
4) The prepared sericin and gamma-polyglutamic acid self-assembled nano-micelle is used for embedding and detecting curcumin hydrophobic drugs. The self-assembly morphology and drug encapsulation data are shown in figure 1 and table 1.
Example 2
A preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle comprises the following steps:
1) selection of sericin and gamma-polyglutamic acid
The molecular weight of the sericin is 12000-24000Da, and the molecular weight of the gamma-polyglutamic acid is selected to be 70 ku.
2) Preparation of sericin and gamma-polyglutamic acid solution
Dissolving a certain mass of sericin and gamma-polyglutamic acid in deionized water to prepare a solution with the mass concentration of 0.9% for later use.
3) Preparation of self-assemblies of sericin and gamma-polyglutamic acid
The preparation process comprises the following steps: mixing sericin and gamma-polyglutamic acid solution with the same mass concentration of 0.9% and the mass ratio of 2:1, adding phthalic acid-hydrochloric acid buffer solution (pH 2.2-3.8) with 3 times volume (0.05 mol/L), finely adjusting the pH value to 3.0 by using 0.01 mol/L, putting the mixture into an ultrasonic device, and carrying out ultrasonic treatment for 2 hours at the power of 300W and the frequency of 40 KHZ. And (3) putting the mixed solution into a reactor, carrying out constant-temperature assembly for 6 hours at the temperature of 30 ℃, then adding 0.01% of cross-linking agent vinyl sulfone, and carrying out cross-linking for 2 hours to fix the structure of the micelle, thus preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid.
4) The prepared sericin and gamma-polyglutamic acid self-assembly nano-micelle is used for embedding the hydrophobic drug β -carotene, and the appearance of the self-assembly and drug embedding data are shown in figure 2 and table 1.
Example 3
A preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle comprises the following steps:
1) selection of sericin and gamma-polyglutamic acid
The molecular weight of the sericin is selected from 12000-24000Da, and the molecular weight of the gamma-polyglutamic acid is selected from 120 ku.
2) Preparation of sericin and gamma-polyglutamic acid solution
The preparation and application environment of the self-assembled micelle are carried out in an acid environment (the pH is less than or equal to 7), and a solution with the mass concentration of 1.2 percent is prepared by dissolving a certain mass of sericin and gamma-polyglutamic acid in deionized water for later use.
3) Preparation of self-assemblies of sericin and gamma-polyglutamic acid
Mixing sericin with a mass concentration of 1.2% and a gamma-polyglutamic acid solution in a mass ratio of 1:1, adding a phthalic acid-hydrochloric acid buffer solution (pH 2.2-3.8) with a volume of 3 times (0.05 mol/L), finely adjusting the pH value to 3.3 by using hydrochloric acid with a volume of 0.01 mol/L, placing the mixture in an ultrasonic device, and carrying out ultrasonic treatment for 2 hours at a power of 300W and a frequency of 40 KHZ. And (3) putting the mixed solution into a reactor, assembling for 10 hours at a constant temperature within a temperature range of 50 ℃, adding 0.03% of cross-linking agent vinyl sulfone, and crosslinking for 3 hours to fix the structure of the micelle, thereby preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid.
4) The prepared sericin and gamma-polyglutamic acid self-assembled nano-micelle is used for embedding the hydrophobic drug curcumin and detecting the embedding and slow release performance of the curcumin. The self-assembly morphology and drug encapsulation data are shown in figure 3 and table 1.
Example 4
A preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle comprises the following steps: 1): selecting sericin with the molecular weight of 15000-20000Da and gamma-polyglutamic acid with the molecular weight of 100 ku; 2) preparing a sericin solution and a gamma-polyglutamic acid solution with the same mass concentration: dissolving sericin with the molecular weight of 15000-20000Da and gamma-polyglutamic acid with the molecular weight of 100ku in deionized water respectively to prepare solutions with the same mass concentration and the range of 2 percent;
3) preparing a sericin and gamma-polyglutamic acid self-assembly: a. mixing the sericin solution with the same mass concentration prepared in the step 2) with the gamma-polyglutamic acid solution according to the mass ratio of 1:2 to prepare a mixed solution; b. adding 2 times volume of phthalic acid-hydrochloric acid buffer solution (pH 2.2-3.8) into the mixed solution, adjusting pH value to (pH 2.2-3.8) with 0.01 mol/L hydrochloric acid, and placing into an ultrasonic device for ultrasonic treatment for 2 hr with ultrasonic power of 300W and frequency of 40 KHZ; c. and c, filling the mixed solution prepared in the step b into a reactor, respectively carrying out constant temperature assembly for 8 hours within the temperature range of (20-50 ℃), then adding 0.1% of cross-linking agent vinyl sulfone, and carrying out cross-linking for 2 hours to fix the structure of the micelle, thus preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid.
4) The prepared sericin and gamma-polyglutamic acid self-assembled nano-micelle is used for embedding the hydrophobic medicine curcumin.
Example 5
A preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle comprises the following steps: 1): selecting sericin with the molecular weight of 16000-18000Da and gamma-polyglutamic acid with the molecular weight of 80 ku; 2) preparing a sericin solution and a gamma-polyglutamic acid solution with the same mass concentration: dissolving sericin with the molecular weight of 16000-18000Da and gamma-polyglutamic acid with the molecular weight of 80ku in deionized water respectively to prepare solutions with the same mass concentration and the range of 2 percent;
3) preparing a sericin and gamma-polyglutamic acid self-assembly: a. mixing the sericin solution with the same mass concentration prepared in the step 2) with the gamma-polyglutamic acid solution according to the mass ratio of 1:4 to prepare a mixed solution; b. adding 2 times volume of phthalic acid-hydrochloric acid buffer solution (pH 2.2-3.8) with concentration of 0.05mol/L into the mixed solution, finely adjusting pH value to (pH 2.2-3.8) within the range by using 0.01 mol/L hydrochloric acid, and placing the mixture into an ultrasonic device for ultrasonic treatment for 2 hours, wherein the ultrasonic power is 300W, and the frequency is 40 KHZ; c. and c, filling the mixed solution prepared in the step b into a reactor, respectively carrying out constant temperature assembly for 8 hours within the temperature range of (20-50 ℃), then adding 0.3% of cross-linking agent vinyl sulfone, and carrying out cross-linking for 1 hour to fix the structure of the micelle, thus preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid.
4) The prepared sericin and gamma-polyglutamic acid self-assembled nano-micelle is used for embedding the hydrophobic medicine curcumin.
TABLE 1 embedding and slow releasing performance of sericin and gamma-polyglutamic acid self-assembled nano micelle
Figure 169048DEST_PATH_IMAGE002
As can be seen from FIGS. 1 to 3, the self-assembled nano-micelles of sericin and gamma-polyglutamic acid prepared by assembly under different conditions have different morphologies and particle sizes, but the self-assembled nano-micelles are all between 30 and 95nm and are nano-micelles, the morphologies of examples 1 and 2 are cubic, and the morphology of example 3 is approximately spherical, and experimental detection shows that the self-assembled nano-micelles have higher entrapment rate and drug loading rate for hydrophobic drugs curcumin or β -carotene according to Table 1.
Compared with the prior art, the invention has the following beneficial technical effects:
1. the invention uses soluble sericin with higher molecular weight and gamma-polyglutamic acid with different molecular weights as raw materials
The raw materials, gamma-polyglutamic acid and natural protein substances are firstly used for preparing the self-assembled nano micelle by the self-assembly technology.
2. The sericin used as a raw material is a byproduct in the textile industry, has low price, and can greatly reduce the preparation cost of the drug carrier when being used with the gamma-polyglutamic acid.
3. The preparation raw materials belong to natural high molecular substances, the preparation process belongs to an environment-friendly preparation process, and no harmful substances are added or introduced, so that the preparation method for preparing the composite micelle in an environment-friendly way is provided.
4. Experiments prove that the nano-composite micelle prepared by the method has higher entrapment rate and drug-loading rate, good slow-release performance and good application prospect.

Claims (4)

1. A preparation method of sericin and gamma-polyglutamic acid self-assembly nano-micelle is characterized by comprising the following steps: 1): selecting sericin with the molecular weight of 12000-24000Da and gamma-polyglutamic acid with the molecular weight of 10-120 ku;
2) preparing a sericin solution and a gamma-polyglutamic acid solution with the same mass concentration: respectively dissolving sericin with the molecular weight of 12000-24000Da and gamma-polyglutamic acid with the molecular weight of 10-120ku in deionized water to prepare solutions with the same mass concentration and the range of 0.3-2%;
3) preparing a sericin and gamma-polyglutamic acid self-assembly;
the preparation steps of the sericin and gamma-polyglutamic acid self-assembly in the step 3) are as follows: a. mixing the sericin solution with the same mass concentration prepared in the step 2) with the gamma-polyglutamic acid solution according to the mass ratio of 4:1 to 1:4 to prepare a mixed solution;
b. adding 1-3 times volume of phthalic acid-hydrochloric acid buffer solution (pH2.2-3.8) with concentration of 0.05mol/L, fine-adjusting pH value to pH2.2-3.7 with 0.01 mol/L hydrochloric acid, and placing in an ultrasonic device for ultrasonic treatment for 1-3 hr;
c. b, filling the mixed solution prepared in the step b into a reactor, respectively carrying out constant temperature assembly for 4-12 hours within the temperature range of 20-50 ℃, then adding a cross-linking agent of vinyl sulfone with the total mass of 0.005-0.1% of the mixed solution, and carrying out cross-linking for 1-3 hours to fix the structure of the micelle, thus preparing the self-assembled nano micelle of sericin and gamma-polyglutamic acid;
the preparation and application environment of the self-assembled micelle in the step 3) is carried out in an acidic environment with pH less than or equal to 7.
2. The method for preparing sericin and gamma-polyglutamic acid self-assembly nano-micelles according to claim 1, wherein: the mixed solution in the step 3) is prepared by mixing the sericin solution and the gamma-polyglutamic acid solution with the same mass concentration according to the mass ratio of 4:1, 2:1, 1:2 and 1: 4.
3. The method for preparing sericin and gamma-polyglutamic acid self-assembly nano-micelles according to claim 1, wherein: and c, performing ultrasonic treatment on the mixed solution in the step b in an ultrasonic device at the power of 300W and the frequency of 40 KHz.
4. The application of the sericin and gamma-polyglutamic acid self-assembly nano-micelle prepared by the preparation method of the sericin and gamma-polyglutamic acid self-assembly nano-micelle according to any one of claims 1 to 3 is characterized by being applied to the embedding of the preparation of hydrophobic drugs curcumin and β carotene.
CN201810353345.3A 2018-04-19 2018-04-19 Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle Active CN108478527B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810353345.3A CN108478527B (en) 2018-04-19 2018-04-19 Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810353345.3A CN108478527B (en) 2018-04-19 2018-04-19 Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle

Publications (2)

Publication Number Publication Date
CN108478527A CN108478527A (en) 2018-09-04
CN108478527B true CN108478527B (en) 2020-05-22

Family

ID=63312605

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810353345.3A Active CN108478527B (en) 2018-04-19 2018-04-19 Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle

Country Status (1)

Country Link
CN (1) CN108478527B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912811B (en) * 2019-03-29 2021-04-06 安徽省农业科学院蚕桑研究所 Preparation method of amphiphilic sericin polymer and application of polymer
CN110664777A (en) 2019-10-11 2020-01-10 杭州协合医疗用品有限公司 Sericin particle with oxidative stress property and preparation method and application thereof
CN110841070A (en) * 2019-11-29 2020-02-28 苏州丝美特生物技术有限公司 Silk fibroin-based material loaded with active ingredients and preparation and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102977594A (en) * 2012-12-13 2013-03-20 上海应用技术学院 Gamma-polyglutamic acid/gelatin nanocapsules and preparation method thereof
CN103301504A (en) * 2013-06-28 2013-09-18 天津工业大学 Preparation method of gamma-polyglutamate/sericin hydrogel dressing
CN107603241A (en) * 2017-09-25 2018-01-19 中原工学院 A kind of preparation method of fusiformis nano-micelle

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102977594A (en) * 2012-12-13 2013-03-20 上海应用技术学院 Gamma-polyglutamic acid/gelatin nanocapsules and preparation method thereof
CN103301504A (en) * 2013-06-28 2013-09-18 天津工业大学 Preparation method of gamma-polyglutamate/sericin hydrogel dressing
CN107603241A (en) * 2017-09-25 2018-01-19 中原工学院 A kind of preparation method of fusiformis nano-micelle

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A novel poly(γ-glutamic acid)/silk-sericin hydrogel for wound dressing:Synthesis, characterization and biological evaluation;Lu Shi et al;《Materials Science and Engineering C》;20141211;第48卷;参见全文 *

Also Published As

Publication number Publication date
CN108478527A (en) 2018-09-04

Similar Documents

Publication Publication Date Title
CN108478527B (en) Preparation method and application of sericin and gamma-polyglutamic acid self-assembly nano micelle
CN1319637C (en) Chitose microsphere and microcapsule with uniform size and its preparation method
CN111317135A (en) Method for embedding slow-release curcumin by polyphenol-modified zein nanoparticles
CN113577376B (en) Double-heavy-load drug polysaccharide-based self-healing hydrogel and preparation method thereof
CN106582465A (en) Method for preparing chitosan/sodium alginate natural polymer core-shell microspheres by one-step process
CN110227069B (en) PH response type tannic acid/chitosan nano-capsule and preparation method thereof
CN104958251A (en) Preparation method of hyaluronic acid nanogel
CN110183601B (en) Preparation method and application of covalent organic framework material containing acylhydrazone bonds and disulfide bonds
CN102688195A (en) Preparation method for doxorubicin hydrochloride-entrapped chitosan carboxymethyl chitosan nanometer controlled-release particle with pH sensibility
CN108578357A (en) A kind of protein-polysaccharide self-assembled nanometer gel and the preparation method and application thereof with nucleocapsid structure
CN102212146B (en) Thioctic acid-modified hydrophilic polymer for side chain
CN102309760A (en) Cationic amphiphilic chitosan nano drug carrier and preparation method and application thereof
CN104119479B (en) Biomimetic amphiphilic graft copolymer with cell membrane structure and preparation method thereof
CN105381472A (en) Evening primrose essence B-casein phosphopeptide-chitosan nano particle, preparation method and applications thereof
CN102010513B (en) Stable polysaccharide modified gelatin nano particle and preparation method and application thereof
CN107737043B (en) Hyaluronic acid-based tea polyphenol-loaded self-assembled nano-composite, and preparation method and application thereof
CN105838013B (en) One kind is based on methyl vinyl ether maleic acid copolymer and the sensitive composite Nano gels of chitosan pH and preparation method thereof
CN102304259B (en) Preparation method of fibroin blending material with gradually degrading performance
Khan et al. Biomedical applications of interpenetrating polymer network gels
CN110721162A (en) Preparation method of nano-microspheres with biological activity
CN102010480B (en) Method for preparing micro-grade polymer gel microspheres capable of loading protein
CN107397962A (en) A kind of poly- (L lysines) VAPG nucleic acid carriers of glucan g and its preparation method and application
CN110585136A (en) Biotin-modified trimethyl chitosan nanoparticles loaded with protein polypeptide and preparation method thereof
CN101906210B (en) Method for synthesizing polypeptide in presence of ammonia-base rare earth catalyst
CN102120823B (en) The synthesis of water solublity zein and the utilization in pharmaceutical preparation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 451191 No. 1 Huaihe Road, Shuang Hu Economic and Technological Development Zone, Xinzheng, Zhengzhou, Henan

Applicant after: Zhongyuan University of Technology

Address before: 451191 No. 1 Huaihe Road, Shuanghu Town Economic and Technological Development Zone, Zhengzhou City, Henan Province

Applicant before: Zhongyuan University of Technology

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant